Drug interactions
Oxybutynin transdermal + Risperidone
Severity: Minor
Oxybutynin transdermal and Risperidone: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Oxybutynin is an antimuscarinic and, even transdermally, adds to the weak anticholinergic effects of risperidone, causing dry mouth, constipation, urinary retention and confusion. Transdermal delivery gives lower systemic levels of active metabolite than oral use, so the effect is generally mild.
What this interaction means in plain words
Oxybutynin transdermal and Risperidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Additive antimuscarinic effects.
What to do
Monitor for constipation, urinary retention and cognitive effects, especially in older adults. No routine dose adjustment is needed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Oxybutynin transdermal and Risperidone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Risperidone
- Ibutilide + Risperidone Contraindicated
- Risperidone + Vandetanib Contraindicated
- Adagrasib + Risperidone Major
- Amiodarone + Risperidone Major
- Amisulpride + Risperidone Major
- Amoxapine + Risperidone Major
Frequently asked questions
Can I take Oxybutynin transdermal with Risperidone?
MediHelp rates the interaction as minor. Oxybutynin transdermal and Risperidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Oxybutynin is an antimuscarinic and, even transdermally, adds to the weak anticholinergic effects of risperidone, causing dry mouth, constipation, urinary retention and confusion. Transdermal delivery gives lower systemic levels of active metabolite than oral use, so the effect is generally mild.
How serious is the interaction between Oxybutynin transdermal and Risperidone?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for constipation, urinary retention and cognitive effects, especially in older adults. No routine dose adjustment is needed.
What other medicines interact with Risperidone?
MediHelp also lists interactions of Risperidone with, for example, Ibutilide, Vandetanib, Adagrasib. The full list is on the Risperidone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
